J.B. CARROLL1, J.A. KATANCIK1, A.J. MORETTI2, and M. MADJID1, 1University of Texas - Houston/Health Science Center, USA, 2University of North Carolina at Chapel Hill, USA |
Objective: HMG
CoA reductase inhibitors (statins) are a class of drugs used for their ability
to lower cholesterol with resultant reductions in cardiac morbidity and
mortality. A growing body of evidence suggests that statins may also exert a
proportion of their beneficial effect on cardiovascular events as a result of
their pleiotropic anti-inflammatory properties. Statins are increasingly being
used for non-cardiac inflammatory diseases such as rheumatoid arthritis and
systemic lupus erythematous. The purpose of this study was to examine the possible
effect of statins – including atorvastatin (Lipitor), simvastatin (Zocor), and
cerivastatin (Crestor) – on the local inflammatory response associated with
periodontal disease.
Methods: This retrospective chart review study
included a total of 235 subjects diagnosed with periodontitis (mean age 54;
21-80) randomly selected from the records of the University of Texas Dental
Branch at Houston Advanced Program in Periodontics. Medical histories were
reviewed and periodontal parameters included plaque score, probing pocket depth
(PPD), clinical attachment level (CAL), bleeding on probing (BOP), mobility,
and furcation involvement.
Results: There was not a significant difference
between groups in mean PPD, smoking status, or plaque levels; however, there
was a significant difference between control and statin subjects in BOP (p <
0.001), age (p<0.001), and CAL (p<0.05); with the statin group being
older on average, having less BOP, and less CAL.
Conclusion: In this study population, individuals
taking statin drugs had significantly less periodontal inflammation, as
measured by BOP, despite equivalent plaque levels, PPD, and smoking status.
| Control (n=154) | Statin (n=81) | Gender | 65 male, 89 female | 40 male, 41 female | *Mean Age (years) | 52 | 59 | Plaque control record (%) | 52 | 50 | Mean probing depths (PD, mm) | 2.94 | 2.89 | *Mean attachment level (CAL, mm) | 2.99 | 2.67 | *Bleeding on probing (BOP %) | 34 | 19 | Tobacco smokers (%) | 17 | 21 | Mean number of cigarettes/day (range) | 12 (1-20) | 15 (3-30) |
|